Characteristics and Outcomes of a Single-Centre Cohort of Adult Congenital Heart Disease Patients Referred for Heart Transplant

被引:2
|
作者
Jayadeva, Pavithra S. [1 ]
Peters, Stacey [1 ]
Tee, Su Ling [2 ]
Burchill, Luke J. [3 ]
Marasco, Silvana F. [2 ]
Grigg, Leeanne [1 ]
Leet, Angeline [2 ]
Mcgif, David
Zentner, Dominica [1 ]
机构
[1] Royal Melbourne Hosp, Dept Cardiol, Melbourne, Vic, Australia
[2] Alfred Hosp, Dept Cardiol & Cardiothorac Surg, Melbourne, Vic, Australia
[3] Mayo Clin, Dept Cardiol, Rochester, MN USA
关键词
Adult congenital heart disease; Heart transplant; Heart failure; MECHANICAL CIRCULATORY SUPPORT; SCIENTIFIC STATEMENT; CHANGING PROFILE; SURVIVAL; REGISTRY; FAILURE; SOCIETY; IMPACT;
D O I
10.1016/j.hlc.2024.02.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Adult congenital heart disease (ACHD) services increasingly encounter heart failure (HF) in the ageing ACHD population. Optimal timing of referral for heart transplant (HTx) evaluation in this heterogeneous population is complex and ill-defined. fi ned. We aim to outline the characteristics and outcomes of ACHD patients referred for HTx from a large Australian ACHD centre. Method Retrospective review of ACHD patients referred for HTx from a primary ACHD centre (1992-2021). Database analysis of patient demographics, characteristics, wait-listing, and transplantation outcomes was performed. Results A total of 45 patients (mean age 37 +/- 9.9 +/- 9.9 years old; 69% male) were referred for HTx with a mean followup of 5.9 +/- 6.3 +/- 6.3 years. Of these, 22 of 45 (49%) were listed and transplanted, including one heart-lung transplant. The commonest diagnosis was dextro-transposition of the great arteries (13/45, 29%). Most patients, 33 of 45 (73.3%) had undergone at least one cardiac surgery in childhood. Indications for HTx referral included HF in 34 of 45 (75%), followed by pulmonary hypertension in 7 of 45 (11%). Median transplant wait-list time was 145 days (interquartile range, 112-256). Of the 23 patients not wait- listed, the reasons included clinical stability in 13 of 45 (29%), psychosocial factors in 2 of 45 (4.4%) and prohibitive surgical risk, including multiorgan dysfunction, in 8 of 45 (17.7%). Transplant was of a single organ in most, 21 of 22 (95.5%). Overall mortality was 5 of 22 (22.7%) in those after HTx, and 14 of 23 (60.9%) in those not listed (p=0.0156). Conclusions Increasingly, ACHD patients demonstrate the need for advanced HF treatments. HTx decision-making is complex, and increased mortality is seen in those not wait-listed. Ultimately, the referral of ACHD patients for HTx is underpinned by local decision-making and experience, wait-list times and outcomes.
引用
收藏
页码:1184 / 1192
页数:9
相关论文
共 50 条
  • [21] CONGENITAL HEART DISEASE IN ADULT PATIENTS Medical therapy for heart failure in adult congenital heart disease: does it work?
    Gallego, Pastora
    Maria Oliver, Jose
    HEART, 2020, 106 (02) : 154 - 162
  • [22] Atrial arrhythmia and heart failure in adult patients with congenital heart disease: a retrospective cohort study
    Lauwers, Charlotte
    Troost, Els
    De Meester, Pieter
    Moons, Philip
    Vandenberk, Bert
    Ector, Joris
    Haemers, Peter
    Budts, Werner
    Van De Bruaene, Alexander
    HEART, 2024,
  • [23] Trends and outcomes of heart transplantation in adults with congenital heart disease
    Alsoufi, Bahaaldin
    Kozik, Deborah
    Perrotta, Melissa
    Wilkens, Sarah
    Lambert, Andrea Nicole
    Deshpande, Shriprasad
    Slaughter, Mark
    Trivedi, Jaimin
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (03)
  • [24] Adult congenital heart disease in Greece: Preliminary data from the CHALLENGE registry
    Giannakoulas, G.
    Vasiliadis, K.
    Frogoudaki, A.
    Ntellos, C.
    Tzifa, A.
    Brili, S.
    Manginas, A.
    Papaphylactou, M.
    Parcharidou, D.
    Kampouridis, N.
    Pitsis, A.
    Chamaidi, A.
    Kolios, M.
    Papadopoulos, G.
    Douras, A.
    Davlouros, P.
    Ntiloudi, D.
    Karvounis, H.
    Kalangos, A.
    Tsioufis, C.
    Rammos, S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 245 : 109 - 113
  • [25] Heart transplantation and in-hospital outcomes in adult congenital heart disease patients with Fontan: A decade nationwide analysis from 2004 to 2014
    Hernandez, Gabriel A.
    Lemor, Alejandro
    Clark, Daniel
    Blumer, Vanessa
    Burstein, Danielle
    Byrne, Ryan
    Fowler, Rachel
    Frischhertz, Benjamin
    Sandhaus, Emily
    Schlendorf, Kelly
    Zalawadiya, Sandip
    Lindenfeld, JoAnn
    Menachem, Jonathan N.
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (03) : 603 - 608
  • [26] Heart transplant for adult congenital heart disease: a battle to overcome early mortality
    Eberly, Logan M.
    Alsoufi, Bahaaldin
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (02)
  • [27] Heart-Lung Transplantation Outcomes in Adult Congenital Heart Disease
    Khan, Asma M.
    Lytrivi, Irene D.
    Rajagopal, Hari
    Nicholson, Lisa M.
    Pahl, Elfriede
    CIRCULATION, 2016, 134
  • [28] General principles of heart failure management in adult congenital heart disease
    Tompkins, Rose
    Romfh, Anitra
    HEART FAILURE REVIEWS, 2020, 25 (04) : 555 - 567
  • [29] The total artificial heart in patients with congenital heart disease
    Thangappan, Karthik
    Ashfaq, Awais
    Villa, Chet
    Morales, David L. S.
    ANNALS OF CARDIOTHORACIC SURGERY, 2020, 9 (02) : 89 - 97
  • [30] Heart Failure in Complex Congenital Heart Disease of the Adult
    Anisa Chaudhry
    Julia Selwyn
    Elizabeth Adams
    Elisa A. Bradley
    Current Cardiology Reports, 2022, 24 : 1727 - 1735